Edition:
United States

People: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

332.00USD
28 Sep 2016
Change (% chg)

$-8.03 (-2.36%)
Prev Close
$343.03
Open
$332.00
Day's High
$332.00
Day's Low
$332.00
Volume
100
Avg. Vol
617
52-wk High
$406.88
52-wk Low
$255.75

Bridgen, John 

Dr. John Bridgen, Ph.D., serves as Senior Vice President - Business Development of Alere Inc. He has served as Senior Vice President, Business Development since July 2010, after serving as our Vice President, Business Development from June 2006 to July 2010. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined the Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.

Basic Compensation

Total Annual Compensation, USD 553,600
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 332,985
Fiscal Year Total, USD 886,585

Options Compensation

  Quantity Market Value
Exercisable 56,664 461,362.00
Unexercisable 50,000 149,500.00
Exercised -- --
Name Fiscal Year Total

Gregg Powers

--

Namal Nawana

4,885,080

James Hinrichs

--

Daniella Cramp

1,674,240

Sanjay Malkani

1,707,390

Avi Pelossof

1,607,070
As Of  30 Dec 2014